Related Experiment Video
Updated: Jul 19, 2026
Primary Culture of Mouse Dopaminergic Neurons
Published on: September 8, 2014
Catalpol protects dopaminergic neurons from LPS-induced neurotoxicity in mesencephalic neuron-glia cultures
Yuan-Yuan Tian1, Li-Jia An, Lan Jiang
1School of Environmental and Biological Science and Technology, Dalian University of Technology, Dalian, Liaoning, 116024, China.
Abstract:
Inflammation plays an important role in the pathogenesis of Parkinson's disease (PD). Microglia, the resident immune cells in the central nervous system, are pivotal in the inflammatory reaction. Activated microglia can induce expression of inducible nitric-oxide synthase (iNOS) and release significant amounts of nitric oxide (NO) and TNF-alpha, which can damage the dopaminergic neurons. Catalpol, an iridoid glycoside, contained richly in the roots of Rehmannia glutinosa, was found to be neuroprotective in gerbils subjected to transient global cerebral ischemia. But the effect of catalpol on inflammation-mediated neurodegeneration has not been examined. In this study, microglia in mesencephalic neuron-glia cultures were activated with lipopolysaccharide (LPS) and the aim of the study was to examine whether catalpol could protect dopaminergic neurons from LPS-induced neurotoxicity. The results showed that catalpol significantly reduced the release of reactive oxygen species (ROS), TNF-alpha and NO after LPS-induced microglial activation. Further, catalpol attenuated LPS-induced the expression of iNOS. As determined by immunocytochemical analysis, pretreatment by catalpol dose-dependently protected dopaminergic neurons against LPS-induced neurotoxicity. These results suggest that catalpol exerts its protective effect on dopaminergic neurons by inhibiting microglial activation and reducing the production of proinflammatory factors. Thus, catalpol may possess therapeutic potential against inflammation-related neurodegenerative diseases.
Insights
Catalpol protects brain cells from inflammation linked to Parkinson's disease. This compound reduces harmful nitric oxide and tumor necrosis factor-alpha, safeguarding dopaminergic neurons from damage.
Area of Science:
- Neuroscience
- Immunology
- Pharmacology
Background:
- Inflammation is key in Parkinson's disease (PD) pathogenesis.
- Microglia activation releases neurotoxic factors like nitric oxide (NO) and TNF-alpha.
- Catalpol, from Rehmannia glutinosa, shows prior neuroprotection but its anti-inflammatory effects in PD are unknown.
Purpose of the Study:
- To investigate catalpol's neuroprotective effects against lipopolysaccharide (LPS)-induced neurotoxicity in microglia-neuron cultures.
- To determine if catalpol can prevent inflammation-mediated damage to dopaminergic neurons.
Main Methods:
- Microglia and mesencephalic neurons were cultured and activated with LPS.
- Catalpol pretreatment was administered to assess its impact on neurotoxicity.
- Levels of reactive oxygen species (ROS), NO, TNF-alpha, and inducible nitric-oxide synthase (iNOS) were measured.
- Immunocytochemistry was used to evaluate dopaminergic neuron survival.
Main Results:
- Catalpol significantly reduced LPS-induced release of ROS, TNF-alpha, and NO.
- Catalpol attenuated the expression of iNOS in activated microglia.
- Pretreatment with catalpol dose-dependently protected dopaminergic neurons from LPS-induced neurotoxicity.
Conclusions:
- Catalpol protects dopaminergic neurons by inhibiting microglial activation.
- Catalpol reduces the production of pro-inflammatory factors, mitigating neurotoxicity.
- Catalpol shows therapeutic potential for treating inflammation-related neurodegenerative diseases like Parkinson's.
